Categories
Archives
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- June 2014
- May 2014
- April 2014
- March 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- March 2010
- February 2010
- January 2010
< Back to Press Releases
Monthly Archives: September 2013
Biological therapy with cediranib improves survival in women with recurrent ovarian cancer
Amsterdam, The Netherlands: Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results presented on Monday at the 2013 European Cancer Congress (ECC2013) [1]. Cediranib, … Continue reading
Published Monday, September 30th, 2013 at 12:30 pm
Posted in Cancer
The State of Oncology 2013 – new report draws attention to urgent need to tackle disparities in cancer care worldwide
Amsterdam, The Netherlands: A proposal for a new financing model to tackle the major disparities that exist in the prevention, diagnosis, treatment and outcome of cancer in countries worldwide has been presented at the 2013 European Cancer Congress (ECCO 2013). … Continue reading
Published Monday, September 30th, 2013 at 9:00 am
Posted in Cancer
New research shows how aspirin may act on blood platelets to improve survival in colon cancer patients
Amsterdam, The Netherlands: Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) [1] heard on Monday. Although previous research has shown that taking low dose aspirin after being … Continue reading
Published Monday, September 30th, 2013 at 8:00 am
Posted in Cancer
First estimate of amount of radiotherapy dose wasted in compensating for tumour growth between treatments
Amsterdam, The Netherlands: For the first time, researchers have estimated the daily dose of radiotherapy that could be wasted in compensating for cancer cell growth that occurs overnight and during weekends in patients with early breast cancer. In research presented … Continue reading
Published Monday, September 30th, 2013 at 8:00 am
Posted in Cancer
Trial combining anti-cancer drug and radiotherapy may lead to new treatment for most aggressive brain tumour
Amsterdam, The Netherlands: Results from a clinical trial of a new treatment for glioblastoma suggest that researchers may have found a new approach to treating this most aggressive of brain tumours, as well as a potential new biological marker than … Continue reading
Published Monday, September 30th, 2013 at 12:01 am
Posted in Cancer
Identifying the disease-causing mechanisms in cancers with an unknown primary site improves treatment and survival
Amsterdam, The Netherlands: Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress (ECC2013) [1] heard on Monday. In up to five percent of all … Continue reading
Published Monday, September 30th, 2013 at 12:01 am
Posted in Cancer
Organised screening for prostate cancer using the prostate-specific antigen test, does more harm than good
Amsterdam, The Netherlands: Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm than good from … Continue reading
Published Monday, September 30th, 2013 at 12:01 am
Posted in Cancer
Promising results for new antibody drug in non-small cell lung cancer patients: smokers respond well
Amsterdam, The Netherlands: New results from a trial of an antibody that helps the immune system to recognise and attack cancer cells have shown particularly encouraging responses in patients who are smokers or former smokers. Presenting the most up-to-date data … Continue reading
Published Sunday, September 29th, 2013 at 9:00 am
Posted in Cancer
Survival after cancer diagnosis in Europe is strongly associated with how much governments spend on health care
Amsterdam, The Netherlands: The more an EU (European Union) national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research presented to the 2013 European Cancer Congress (ECC2013) [1] on Sunday … Continue reading
Published Sunday, September 29th, 2013 at 12:05 am
Posted in Cancer
Colorectal cancer screening works; ‘irrefutable’ evidence that fall in death rates is attributable to screening programmes
Amsterdam, The Netherlands: Screening for colorectal cancer (CRC) in European countries is highly effective in reducing mortality from the disease. Some of the resources currently being devoted to breast and prostate screening programmes, where the evidence of effectiveness is much … Continue reading
Published Sunday, September 29th, 2013 at 12:01 am
Posted in Cancer